BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3034644)

  • 1. Intermediate filament expression in small cell lung cancer; poor correlation to in vitro data.
    Berendsen HH; de Ley L; Poppema S; Postmus PE; Sluiter HJ; The TH
    Eur J Respir Dis Suppl; 1987; 149():19-27. PubMed ID: 3034644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation.
    Bergh J; Nilsson K; Dahl D; Andersson L; Virtanen I; Lehto VP
    Lab Invest; 1984 Sep; 51(3):307-16. PubMed ID: 6206304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.
    Banks-Schlegel SP; Gazdar AF; Harris CC
    Cancer Res; 1985 Mar; 45(3):1187-97. PubMed ID: 2578876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies.
    Broers JL; Carney DN; Klein Rot M; Schaart G; Lane EB; Vooijs GP; Ramaekers FC
    J Cell Sci; 1986 Jul; 83():37-60. PubMed ID: 2433295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of the major human tumor groups using conventional and monoclonal antibodies specific for individual intermediate filament proteins.
    Osborn M; Altmannsberger M; Debus E; Weber K
    Ann N Y Acad Sci; 1985; 455():649-68. PubMed ID: 2417533
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential expression of intermediate filament proteins distinguishes classic from variant small-cell lung cancer cell lines.
    Broers JL; Carney DN; de Ley L; Vooijs GP; Ramaekers FC
    Proc Natl Acad Sci U S A; 1985 Jul; 82(13):4409-13. PubMed ID: 2409557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of three new variant type cell lines derived from small cell carcinoma of the lung.
    de Leij L; Postmus PE; Buys CH; Elema JD; Ramaekers F; Poppema S; Brouwer M; van der Veen AY; Mesander G; The TH
    Cancer Res; 1985 Dec; 45(12 Pt 1):6024-33. PubMed ID: 2998591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of phosphorylated and non-phosphorylated neurofilament subunits and cytokeratins in neuroendocrine lung tumors.
    Leoncini P; Bellizzi de Marco E; Bugnoli M; Mencarelli C; Vindigni C; Cintorino M
    Pathol Res Pract; 1989 Dec; 185(6):848-55. PubMed ID: 2482482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lung tumours may coexpress different classes of intermediate filaments.
    Gatter KC; Dunnill MS; Van Muijen GN; Mason DY
    J Clin Pathol; 1986 Sep; 39(9):950-4. PubMed ID: 3020094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies.
    Rosen ST; Mulshine JL; Cuttitta F; Fedorko J; Carney DN; Gazdar AF; Minna JD
    Cancer Res; 1984 May; 44(5):2052-61. PubMed ID: 6713399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratin subtypes of small cell lung cancer.
    Elias AD; Cohen BF; Bernal SD
    Cancer Res; 1988 May; 48(10):2724-9. PubMed ID: 2452011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells.
    Doyle LA; Cuttitta F; Mulshine JL; Bunn PA; Minna JD
    Cancer Res; 1987 Oct; 47(19):5009-13. PubMed ID: 3040237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
    Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA
    Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies that distinguish non-small cell from small cell lung cancer.
    Mulshine JL; Cuttitta F; Bibro M; Fedorko J; Fargion S; Little C; Carney DN; Gazdar AF; Minna JD
    J Immunol; 1983 Jul; 131(1):497-502. PubMed ID: 6306102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.
    Kyoizumi S; Akiyama M; Kouno N; Kobuke K; Hakoda M; Jones SL; Yamakido M
    Cancer Res; 1985 Jul; 45(7):3274-81. PubMed ID: 4005855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of intermediate filaments in cultured cells].
    Ning AL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Oct; 10(5):321-4. PubMed ID: 2978249
    [No Abstract]   [Full Text] [Related]  

  • 19. Autocrine growth factors in human small cell lung cancer.
    Cuttitta F; Carney DN; Mulshine J; Moody TW; Fedorko J; Fischler A; Minna JD
    Cancer Surv; 1985; 4(4):707-27. PubMed ID: 2445479
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential diagnosis of lymph node aspirates by intermediate filament typing of tumor cells.
    Domagala W; Weber K; Osborn M
    Acta Cytol; 1986; 30(3):225-34. PubMed ID: 3521173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.